BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia
Dysregulation of B cell receptor (BCR) signalling is a hallmark of chronic lymphocytic leukaemia (CLL) pathology, and targeting BCR pathway kinases has brought great therapeutic advances. Activation of the BCR in lymphoid organs has been associated with CLL cell proliferation and survival, leading to progressive disease. While these responses are mediated predominantly by IgM, the role of IgD is less clear. Seeking to uncover downstream consequences of individual and combined stimulation of the two BCR isotypes, we found an amplification of IgD expression and IgD-mediated calcium signalling by previous stimulation of IgM in CLL. Furthermore, no heterologous downmodulation of the isotypes, as observed in healthy donors, was present. Only marginal downregulation of the expression of various chemokine receptors by α-IgM and α-IgD stimulation was found as compared to normal B cells. Consistently, calcium responses of CLL cells to different chemokines were only weakly affected by preceding BCR activation. In contrast, migration towards the two homeostatic chemokines CXCL12 and CCL21 was differentially regulated by IgM and IgD. While IgM activation reduced migration of CLL cells towards CXCL12, but not CCL21, IgD activation predominantly impacted on CCL21 but not CXCL12-mediated chemotaxis. This indicates that the preference for one chemokine over the other may depend on the functional presence of the two isotypes in CLL. Inhibitors against the kinases Syk, Lyn, and Btk antagonised both BCR- and chemokine-induced calcium signals.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:95 |
|---|---|
| Enthalten in: |
Annals of hematology - 95(2016), 12 vom: 19. Dez., Seite 1979-1988 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Haerzschel, Andrea [VerfasserIn] |
|---|
| Themen: |
Anti-IgD |
|---|
| Anmerkungen: |
Date Completed 27.01.2017 Date Revised 13.11.2018 published: Print-Electronic Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM263594718 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM263594718 | ||
| 003 | DE-627 | ||
| 005 | 20231224204237.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0878.xml |
| 035 | |a (DE-627)NLM263594718 | ||
| 035 | |a (NLM)27542958 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Haerzschel, Andrea |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.01.2017 | ||
| 500 | |a Date Revised 13.11.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Dysregulation of B cell receptor (BCR) signalling is a hallmark of chronic lymphocytic leukaemia (CLL) pathology, and targeting BCR pathway kinases has brought great therapeutic advances. Activation of the BCR in lymphoid organs has been associated with CLL cell proliferation and survival, leading to progressive disease. While these responses are mediated predominantly by IgM, the role of IgD is less clear. Seeking to uncover downstream consequences of individual and combined stimulation of the two BCR isotypes, we found an amplification of IgD expression and IgD-mediated calcium signalling by previous stimulation of IgM in CLL. Furthermore, no heterologous downmodulation of the isotypes, as observed in healthy donors, was present. Only marginal downregulation of the expression of various chemokine receptors by α-IgM and α-IgD stimulation was found as compared to normal B cells. Consistently, calcium responses of CLL cells to different chemokines were only weakly affected by preceding BCR activation. In contrast, migration towards the two homeostatic chemokines CXCL12 and CCL21 was differentially regulated by IgM and IgD. While IgM activation reduced migration of CLL cells towards CXCL12, but not CCL21, IgD activation predominantly impacted on CCL21 but not CXCL12-mediated chemotaxis. This indicates that the preference for one chemokine over the other may depend on the functional presence of the two isotypes in CLL. Inhibitors against the kinases Syk, Lyn, and Btk antagonised both BCR- and chemokine-induced calcium signals | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a BCR signalling | |
| 650 | 4 | |a CLL | |
| 650 | 4 | |a Chemokines | |
| 650 | 4 | |a IgD | |
| 650 | 4 | |a IgM | |
| 650 | 7 | |a Antibodies, Anti-Idiotypic |2 NLM | |
| 650 | 7 | |a CCL21 protein, human |2 NLM | |
| 650 | 7 | |a CXCL12 protein, human |2 NLM | |
| 650 | 7 | |a Chemokine CCL21 |2 NLM | |
| 650 | 7 | |a Chemokine CXCL12 |2 NLM | |
| 650 | 7 | |a Chemokines |2 NLM | |
| 650 | 7 | |a Receptors, Antigen, B-Cell |2 NLM | |
| 650 | 7 | |a anti-IgD |2 NLM | |
| 650 | 7 | |a anti-IgM |2 NLM | |
| 700 | 1 | |a Catusse, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Hutterer, Evelyn |e verfasserin |4 aut | |
| 700 | 1 | |a Paunovic, Manuela |e verfasserin |4 aut | |
| 700 | 1 | |a Zirlik, Katja |e verfasserin |4 aut | |
| 700 | 1 | |a Eibel, Hermann |e verfasserin |4 aut | |
| 700 | 1 | |a Krenn, Peter W |e verfasserin |4 aut | |
| 700 | 1 | |a Hartmann, Tanja N |e verfasserin |4 aut | |
| 700 | 1 | |a Burger, Meike |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of hematology |d 1991 |g 95(2016), 12 vom: 19. Dez., Seite 1979-1988 |w (DE-627)NLM012918768 |x 1432-0584 |7 nnns |
| 773 | 1 | 8 | |g volume:95 |g year:2016 |g number:12 |g day:19 |g month:12 |g pages:1979-1988 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 95 |j 2016 |e 12 |b 19 |c 12 |h 1979-1988 | ||